Representative before the EPO

Company dna m r hutchins and co ltd
no operation time available
Headquarter in Tunbridge Wells
active in Legal Services

Representative before the EPO

Company dna palmer biggs patents limited
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Company dna schlich
no operation time available
708.88
2 offices
active in Legal Services

We have observed 19 EP applications Michael Richard Hutchins has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12770238

COMPOUNDS FOR USE IN CANCER THERAPY

IPC classification:
A61K 31/515, A61P 35/00
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP12845964

METHODS, FORMULATIONS, AND KITS FOR RAPIDLY REPLETING FOLATE LEVELS IN WOMEN

IPC classification:
A61K 31/519, C07D 475/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP12791446

SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION

IPC classification:
A61K 31/137, A61K 31/415, A61K 31/4164, A61K 31/44, A61P 31/12, C07C 217/58, C07D 209/14, C07D 213/75, C07D 231/12, C07D 233/24, C07D 233/64, C07D 295/02, C07D 305/06, C07D 305/08, C07D 309/14
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12810111

PHARMACEUTICALLY ACTIVE PYRAZINE DERIVATIVES

IPC classification:
A61K 31/4965, A61K 31/497, A61P 35/00, C07D 241/12, C07D 241/26, C07D 403/12, C07D 413/12
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13702642

AURORA AND FLT3 KINASES MODULATORS

IPC classification:
A61K 31/496, A61P 35/00, C07D 413/14
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13703308

4,6-SUBSTITUTED 2,5-DIDEOXYSTREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS

IPC classification:
C07H 15/234
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13725184

APPARATUS FOR INVENTORY CONTROL

IPC classification:
G07F 5/26, G07F 9/02, G07F 13/02, G07F 13/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP14754200

TRICYCLIC HETEROCYCLES AS ANTICANCER AGENTS

IPC classification:
A61K 31/542
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15179511

A MOUNT FOR A LAPTOP COMPUTER

IPC classification:
A47F 7/024, E05B 73/00, F16M 11/04, F16M 13/00, G06F 1/16, H04M 1/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
APPLICATION PUBLISHED
EP16150956

TYK2 KINASE INHIBITORS

IPC classification:
A61K 31/421, A61K 31/422, A61P 17/06, A61P 29/00, A61P 37/06, C07D 263/48, C07D 413/12
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP13157419

TYK2 kinase inhibitors

IPC classification:
A61K 31/421, A61K 31/422, A61P 17/06, A61P 29/00, A61P 37/06, C07D 263/48, C07D 413/12
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14841419

AN APPARATUS FOR REMOVING IMPURITIES FROM A FLUID STREAM

IPC classification:
B04B 1/00, B04B 5/10, B04B 9/06, B04B 11/02, B04B 11/06
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15746362

PHARMACEUTICAL COMPOUNDS

IPC classification:
A61K 31/4965, A61K 31/497, C07D 403/12
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP11707070

A COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY

IPC classification:
A61K 35/74, A61K 38/47
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
OPPOSITION REJECTED
EP15712746

SULFONAMIDES DERIVED FROM TRICYCLYL-2-AMINOCYCLOALKANOLS AS ANTICANCER AGENTS

IPC classification:
A61K 31/404, A61K 31/407, A61K 31/437, A61K 31/519, A61K 31/538, A61K 31/551, A61K 31/553, A61P 3/10, A61P 35/00, A61P 37/00, C07C 311/29, C07D 209/86, C07D 243/38, C07D 265/38, C07D 267/18, C07D 471/04, C07D 495/04
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15712745

CONSTRAINED TRICYCLIC SULFONAMIDES

IPC classification:
A61K 31/18, A61K 31/5415, A61K 31/55, A61P 3/10, A61P 17/10, A61P 25/00, A61P 31/12, A61P 33/00, A61P 35/00, A61P 37/00, C07C 311/29, C07D 223/26, C07D 223/28, C07D 223/32, C07D 279/36
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15717224

PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUED PHENYL- (1, 3-DIHYDRO-ISOINDOL-2-YL) -METHANONE

IPC classification:
A61K 31/496, A61K 47/02, A61K 47/12, A61P 35/00
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15783771

MATRIX-FREE POLYMER NANOCOMPOSITES AND RELATED PRODUCTS AND METHODS THEREOF

IPC classification:
C08G 79/02
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15738106

OSTOMY BAG

IPC classification:
A61F 5/445
Agent:
Michael Richard Hutchins, Schlich LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature